OKUR Onkure Therapeutics, Inc.
Fundamentals / CIK 0001637715 / USDOnkure Therapeutics, Inc. reported $167.1M in total assets and a net loss of $61.85M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OKUR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$65.99M Operating profit
-
Net Income FY 2025-$61.85M GAAP bottom line
-
Diluted EPS FY 2025-$1.24 Split-adjusted
-
Free Cash Flow FY 2025-$47.94M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$163.3M Total debt: $790K
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | -- | $0 | -- | -- | -- | -- |
| Research & Development | $48.26M | $43.80M | $32.12M | $37.70M | $28.17M | $15.94M |
| Total Operating Expenses | $62.95M | $54.39M | $36.93M | $53.85M | $39.82M | $19.55M |
| Operating Income | -$62.95M | -$54.39M | -$36.93M | -$53.85M | -$39.82M | -$19.55M |
| EBITDA | -$62.50M | -$53.93M | -$36.52M | -$53.76M | -$39.77M | -$19.52M |
| Interest Income | $3.44M | $2.01M | $1.62M | -- | -- | -- |
| Income Before Tax | -- | -- | -$77.39M | -$51.95M | -$39.77M | -$19.46M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$59.52M | -$52.67M | -$35.31M | -$51.95M | -$39.77M | -$19.46M |
| Basic EPS | -$4.40 | -$15.28 | -$124.41 | -$21.20 | -$21.90 | -$96.00 |
| Diluted EPS | -$4.40 | -$15.28 | -$124.41 | -$21.20 | -$21.90 | -$96.00 |
| Basic Shares Outstanding | 13.5M | 3.4M | 283.8K | 2.4M | 1.8M | 202.8K |
| Diluted Shares Outstanding | 13.5M | 3.4M | 283.8K | 2.4M | 1.8M | 202.8K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $15.06M | $12.61M | $11.71M | $10.72M | $11.91M | $12.61M | $13.01M | $14.36M |
| Total Operating Expenses | $19.35M | $16.90M | $15.62M | $14.12M | $15.50M | $16.32M | $17.00M | $18.70M |
| Operating Income | -$19.35M | -$16.90M | -$15.62M | -$14.12M | -$15.50M | -$16.32M | -$17.00M | -$18.70M |
| EBITDA | -$19.30M | -$16.81M | -$15.51M | -$14.02M | -$15.39M | -$16.21M | -$16.88M | -$18.58M |
| Interest Income | $1.50M | $1.55M | $458K | $628K | $804K | $934K | $1.07M | $1.31M |
| Net Income | -$17.85M | -$15.35M | -$15.16M | -$13.50M | -$14.70M | -$15.39M | -$15.93M | -$17.44M |
| Basic EPS | -$0.36 | -$0.31 | -$1.11 | -- | -$1.09 | -$1.14 | -$1.19 | -- |
| Diluted EPS | -$0.36 | -$0.31 | -$1.11 | -- | -$1.09 | -$1.14 | -$1.19 | -- |
| Basic Shares Outstanding | 49.9M | 49.9M | 13.7M | -- | 13.5M | 13.5M | 13.4M | -- |
| Diluted Shares Outstanding | 49.9M | 49.9M | 13.7M | -- | 13.5M | 13.5M | 13.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $59.05M | $110.8M | $29.88M | $19.93M | $124.7M | $53.61M |
| Short-Term Investments | $0 | -- | $75.33M | $81.25M | $23.01M | -- |
| Cash & Short-Term Investments | $59.05M | $110.8M | $105.2M | $101.2M | $147.7M | $53.61M |
| Total Current Assets | $60.84M | $113.0M | $33.77M | $106.4M | $153.7M | $55.02M |
| Property, Plant & Equipment, Net | $618K | $1.02M | $1.43M | $453K | $212K | $69K |
| Other Non-Current Assets | $273K | $109K | $58K | $84K | $78K | $127K |
| Total Non-Current Assets | $1.28M | $1.90M | $1.97M | $1.83M | $290K | $196K |
| Total Assets | $62.12M | $114.9M | $35.73M | $108.2M | $154.0M | $55.22M |
| Accounts Payable | $1.43M | $2.97M | $3.42M | $1.89M | $2.02M | $908K |
| Total Current Liabilities | $5.92M | $10.53M | $7.29M | $7.12M | $6.20M | $4.58M |
| Other Non-Current Liabilities | $12K | -- | -- | -- | $167K | -- |
| Total Non-Current Liabilities | $12K | $549K | $466K | $1.09M | $611K | $36K |
| Total Liabilities | $5.93M | $11.08M | $7.75M | $8.21M | $6.81M | $4.62M |
| Total Debt (incl. Leases) | $549K | $1.08M | $674K | $1.46M | -- | -- |
| Common Stock | -- | -- | $0 | $3.0K | $3.0K | -- |
| Retained Earnings | -$214.2M | -$154.7M | -$102.1M | -$136.7M | -$84.73M | -$44.96M |
| Accumulated Other Comp. Income | $0 | -- | $8.0K | -$43K | $34K | -- |
| Total Stockholders' Equity | $56.18M | $103.8M | -$101.8M | -$54.42M | $147.2M | -$42.12M |
| Total Equity | $56.18M | $103.8M | -$101.8M | -$54.42M | $147.2M | -$42.12M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $151.4M | $166.5M | $192.1M | $59.05M | $70.33M | $83.37M | $96.66M | $110.8M |
| Short-Term Investments | $11.86M | $9.88M | -- | $0 | -- | -- | -- | -- |
| Cash & Short-Term Investments | $163.3M | $176.4M | $192.1M | $59.05M | $70.33M | $83.37M | $96.66M | $110.8M |
| Total Current Assets | $165.6M | $177.7M | $197.5M | $60.84M | $71.53M | $84.55M | $98.17M | $113.0M |
| Property, Plant & Equipment, Net | $414K | $435K | $519K | $618K | $720K | $821K | $925K | $1.02M |
| Other Non-Current Assets | $409K | $401K | $405K | $273K | $104K | $116K | $109K | $109K |
| Total Non-Current Assets | $1.48M | $1.68M | $1.21M | $1.28M | $1.31M | $1.52M | $1.71M | $1.90M |
| Total Assets | $167.1M | $179.4M | $198.7M | $62.12M | $72.83M | $86.07M | $99.88M | $114.9M |
| Accounts Payable | $2.31M | $2.00M | $11.02M | $1.43M | $1.29M | $2.38M | $2.34M | $2.97M |
| Total Current Liabilities | $8.79M | $6.64M | $14.33M | $5.92M | $6.25M | $7.60M | $8.79M | $10.53M |
| Other Non-Current Liabilities | $12K | $12K | $12K | $12K | $40K | $40K | $40K | -- |
| Total Non-Current Liabilities | $551K | $602K | $12K | $12K | $160K | $307K | $449K | $549K |
| Total Liabilities | $9.34M | $7.25M | $14.34M | $5.93M | $6.41M | $7.90M | $9.23M | $11.08M |
| Total Debt (incl. Leases) | $790K | $926K | $409K | $549K | $687K | $823K | $955K | $1.08M |
| Retained Earnings | -$262.6M | -$244.7M | -$229.4M | -$214.2M | -$200.7M | -$186.0M | -$170.6M | -$154.7M |
| Accumulated Other Comp. Income | -$30K | -$13K | -- | $0 | -- | -- | -- | -- |
| Total Stockholders' Equity | $157.7M | $172.1M | $184.4M | $56.18M | $66.43M | $78.17M | $90.65M | $103.8M |
| Total Equity | $157.7M | $172.1M | $184.4M | $56.18M | $66.43M | $78.17M | $90.65M | $103.8M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$59.52M | -$52.67M | -$35.31M | -$51.95M | -$39.77M | -$19.46M |
| Depreciation & Amortization | $447K | $459K | $417K | $88K | $50K | $37K |
| Stock-Based Compensation | $11.63M | $4.53M | $199K | $4.32M | $3.89M | $393K |
| Operating Cash Flow | -$51.83M | -$51.12M | -$34.55M | -$47.36M | -$37.98M | -$18.54M |
| Capital Expenditure | -$46K | -$52K | -$246K | -$346K | -$198K | -$24K |
| Free Cash Flow | -$51.87M | -$51.17M | -$34.79M | -$47.71M | -$38.18M | -$18.56M |
| Purchases of Investments | -- | -- | -$231.3M | -$101.6M | -$31.41M | -- |
| Investing Cash Flow | -$46K | $15.87M | -$246K | -$57.84M | -$23.38M | $7.38M |
| Common Stock Issued | -- | -- | -- | $193K | $84.61M | -- |
| Share Repurchases | -- | -- | -$4.40M | -- | -- | -- |
| Financing Cash Flow | $163K | $116.1M | $53.12M | $471K | $132.4M | $47.27M |
| Net Change in Cash | -$51.71M | $80.89M | $18.33M | -$104.7M | $71.05M | $36.11M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$17.85M | -$15.35M | -$15.16M | -$13.50M | -$14.70M | -$15.39M | -$15.93M | -$17.44M |
| Depreciation & Amortization | $53K | $87K | $104K | $104K | $108K | $117K | $118K | $116K |
| Stock-Based Compensation | $3.49M | $3.05M | $2.78M | $3.02M | $2.96M | $2.91M | $2.75M | $2.53M |
| Operating Cash Flow | -$13.08M | -$10.35M | -$12.94M | -$11.51M | -$13.04M | -$13.27M | -$14.01M | -$23.35M |
| Capital Expenditure | -$32K | -$3.0K | -$5.0K | -$9.0K | -$6.0K | -$13K | -$18K | -$15K |
| Free Cash Flow | -$13.11M | -$10.36M | -$12.94M | -$11.52M | -$13.04M | -$13.29M | -$14.02M | -$23.37M |
| Investing Cash Flow | -$1.97M | -$9.87M | -$5.0K | -$9.0K | -$6.0K | -$13K | -$18K | $15.91M |
| Financing Cash Flow | -$8.0K | -$5.38M | $146.0M | $240K | $0 | $0 | -$77K | $110.2M |
| Net Change in Cash | -$15.06M | -$25.60M | $133.1M | -$11.28M | -$13.04M | -$13.29M | -$14.10M | $102.8M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -105.9% | -50.7% | -- | -- | -27.0% | -- |
| Return on Assets (ROA) | -95.8% | -45.8% | -98.8% | -48.0% | -25.8% | -35.2% |
| Current Ratio | 10.28x | 10.73x | 4.64x | 14.93x | 24.79x | 12.01x |
| Quick Ratio | 9.97x | 10.52x | 14.44x | 14.20x | 23.81x | 11.71x |
| Debt to Equity | 0.01x | 0.01x | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -39.2% | -34.1% | -31.9% | -105.9% | -95.5% | -77.2% | -65.2% | -50.7% |
| Return on Assets (ROA) | -37.0% | -32.7% | -29.6% | -95.8% | -87.1% | -70.1% | -59.1% | -45.8% |
| Current Ratio | 18.84x | 26.75x | 13.78x | 10.28x | 11.45x | 11.13x | 11.17x | 10.73x |
| Quick Ratio | 18.58x | 26.55x | 13.41x | 9.97x | 11.26x | 10.97x | 11.00x | 10.52x |
| Debt to Equity | 0.01x | 0.01x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -188.6% |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -194.2% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -348.9% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -350.4% |